Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dabrafenib and trametinib cost?Does lipitor's use influence blood pressure medication type?Drugpatentwatch trametinib?Dabrafenib patent expiration date novartis gsk composition matter?How does paclitaxel's binding to albumin change its pharmacokinetics?
See the DrugPatentWatch profile for ozempic
Ozempic’s active ingredient is semaglutide [1]. Semaglutide is a synthetic version of a glucagon-like peptide-1 (GLP-1) hormone used to help manage blood sugar in adults with type 2 diabetes [1].
Semaglutide is a GLP-1 receptor agonist that is engineered as a modified peptide. Its structure includes: - The GLP-1 peptide backbone (the part that binds GLP-1 receptors). - Chemical modifications that help the molecule stay in the body longer, which supports once-weekly dosing for Ozempic [1]. Those dosing-enabling modifications are the core reason semaglutide is considered chemically “unique” compared with earlier GLP-1 medicines.
Ozempic is a peptide-based medicine, not a traditional small-molecule drug. Its identity is the peptide drug semaglutide [1].
The unique chemical makeup refers to the active molecule (semaglutide). Ozempic also contains other inactive ingredients typical of injectable formulations, but the defining pharmacologic chemistry is semaglutide itself [1].
For precise chemical structure details (molecular formula/structure identifiers), the product’s active ingredient—semaglutide—is the reference point. Ozempic is formulated as a semaglutide injection [1].
Other Questions About Ozempic :